On April 15, 2019 Chemesis International (CSI.C) announced plans to purchase a cannabis manufacturing facility in Arizona, that is already up-and-running, generating about $1.3 million in Q1, 2019.
With a 3,000 lb cultivation facility in Puerto Rico, a Colombian grow facility in development, manufacturing and extractions biz (2,000 lb capacity) in California and distribution to retail storefronts in California – CSI is on the move.
The 5,000 square feet Arizona manufacturing facility is a “turn key solution” that produces 100% cannabidiol (CBD)-based products, such as “hard and soft-capsules, cartridges, lotions, tinctures, and other liquid formulations.”
Chemesis has also signed an endorsement deal with a duo that Equity Guru’s Chris Parry calls, “One of the top three best endorsement targets (for a cannabis company) in the world today.” Hint: one of them doesn’t speak.
Edgar Montero, the CEO of Chemesis, spoke with Equity.Guru’s Guy Bennett about the personal catalyst that propelled him into the cannabis industry, and how CSI cross-pollinates innovation between its international operations.
Listen in!
Full disclosure: Chemesis International is an Equity.Guru marketing client.